Cargando…

Evaluation of Benefit and Tolerability of IQP‐CL‐101 (Xanthofen) in the Symptomatic Improvement of Irritable Bowel Syndrome: A Double‐Blinded, Randomised, Placebo‐Controlled Clinical Trial

Irritable bowel syndrome (IBS) is a functional bowel disorder of unknown aetiology. There is currently no known cure, and pharmacological interventions are usually targeting symptomatic relief, where natural and herbal remedies also play a role. This study aimed to evaluate the benefit and tolerabil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alt, Felix, Chong, Pee‐Win, Teng, Emily, Uebelhack, Ralf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518189/ https://www.ncbi.nlm.nih.gov/pubmed/28508427 http://dx.doi.org/10.1002/ptr.5826

Ejemplares similares

Weight Maintenance with Litramine (IQP-G-002AS): A 24-Week Double-Blind, Randomized, Placebo-Controlled Study
por: Grube, Barbara, et al.
Publicado: (2015)

Sleep Promoting Effects of IQP-AO-101: A Double-Blind, Randomized, Placebo-Controlled Exploratory Trial
por: Bongartz, Udo, et al.
Publicado: (2019)

A Review of the Efficacy and Safety of Litramine IQP-G-002AS, an Opuntia ficus-indica Derived Fiber for Weight Management
por: Chong, Pee-Win, et al.
Publicado: (2014)

Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects
por: Uebelhack, Ralf, et al.
Publicado: (2019)

Erratum to “Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects”
por: Uebelhack, Ralf, et al.
Publicado: (2019)

IQP-GC-101 Reduces Body Weight and Body Fat Mass: A Randomized, Double-Blind, Placebo-Controlled Study
por: Chong, Pee-Win, et al.
Publicado: (2014)

Investigation of the natural supplement IQP-AS-119 for the prevention of upper respiratory tract infections in marathon race participants: A randomized, double-blind, placebo-controlled pilot study
por: Bongartz, Udo, et al.
Publicado: (2021)

Microbiota Composition and Diversity in Weight Loss Population After the Intake of IQP-AE-103 in a Double-Blind, Randomized, Placebo-Controlled Study
por: Peng, Li Vern, et al.
Publicado: (2022)

Effects of Cactus Fiber on the Excretion of Dietary Fat in Healthy Subjects: A Double Blind, Randomized, Placebo-Controlled, Crossover Clinical Investigation
por: Uebelhack, Ralf, et al.
Publicado: (2014)

IQP-VV-102, a Novel Proprietary Composition for Weight Reduction: A Double-Blind Randomized Clinical Trial for Evaluation of Efficacy and Safety
por: Grube, Barbara, et al.
Publicado: (2015)

In Vitro and Ex Vivo Evaluations on Transdermal Delivery of the HIV Inhibitor IQP-0410
por: Ham, Anthony S., et al.
Publicado: (2013)

Corrigendum to “IQP-VV-102, a Novel Proprietary Composition for Weight Reduction: A Double-Blind Randomized Clinical Trial for Evaluation of Efficacy and Safety”
por: Grube, Barbara, et al.
Publicado: (2016)

Symptomatic improvement with gluten restriction in irritable bowel syndrome: a prospective, randomized, double blinded placebo controlled trial
por: Zanwar, Vinay G, et al.
Publicado: (2016)

Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
por: Padhy, Susanta Kumar, et al.
Publicado: (2015)

Placebo Effect in Clinical Trial Design for Irritable Bowel Syndrome
por: Shah, Eric, et al.
Publicado: (2014)

Prediction of symptomatic improvement after exposure-based treatment for irritable bowel syndrome
por: Ljótsson, Brjánn, et al.
Publicado: (2013)

Supplementation With Bifidobacterium and Symptomatic Control in Irritable Bowel Syndrome: An Evidence-Based Review
por: Terra, Inês, et al.
Publicado: (2023)

Benefits from Long-Term Treatment in Irritable Bowel Syndrome
por: Evangelista, Stefano
Publicado: (2012)

Irritable bowel syndrome symptom severity improves equally with probiotic and placebo
por: Lyra, Anna, et al.
Publicado: (2016)

A Natural Fiber Complex Reduces Body Weight in the Overweight and Obese: A Double-Blind, Randomized, Placebo-Controlled Study
por: Grube, Barbara, et al.
Publicado: (2013)

Effects of aged garlic extract on arterial elasticity in a placebo-controlled clinical trial using EndoPAT™ technology
por: Gruenwald, Joerg, et al.
Publicado: (2020)

Placebos without Deception: A Randomized Controlled Trial in Irritable Bowel Syndrome
por: Kaptchuk, Ted J., et al.
Publicado: (2010)

Probiotic vs. Placebo in Irritable Bowel Syndrome:A Randomized Controlled Trial
por: Amirimani, Behnaz, et al.
Publicado: (2013)

Systematic review: The placebo effect of psychological interventions in the treatment of irritable bowel syndrome
por: Flik, Carla E, et al.
Publicado: (2017)

Rifaximin for Irritable Bowel Syndrome: A Meta-Analysis of Randomized Placebo-Controlled Trials
por: Li, Jun, et al.
Publicado: (2016)

Randomised clinical trial: minesapride vs placebo for irritable bowel syndrome with predominant constipation
por: Hamatani, Tatsuto, et al.
Publicado: (2020)

Irritable Bowel Syndrome
por: Farup, Per G., et al.
Publicado: (2012)

Defining the irritable bowel
por: Chuah, Kee Huat, et al.
Publicado: (2022)

The Effect of Bifidobacterium on Reducing Symptomatic Abdominal Pain in Patients with Irritable Bowel Syndrome: A Systematic Review
por: Pratt, Charlotte, et al.
Publicado: (2019)

Irritable Brain Caused by Irritable Bowel? A Nationwide Analysis for Irritable Bowel Syndrome and Risk of Bipolar Disorder
por: Liu, Chia-Jen, et al.
Publicado: (2015)

Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial
por: Bijkerk, C J, et al.
Publicado: (2009)

Will controlled release mebeverine be able to surpass placebo in treatment of diarrhoea predominant irritable bowel syndrome?
por: Chakraborty, Dwaipayan Sarathi, et al.
Publicado: (2019)

Genomic Effects Associated With Response to Placebo Treatment in a Randomized Trial of Irritable Bowel Syndrome
por: Wang, Rui-Sheng, et al.
Publicado: (2022)

Effect of TongXie-YaoFang on Cl(−) and HCO(3) (−) Transport in Diarrhea-Predominant Irritable Bowel Syndrome Rats
por: Lu, Xiaofang, et al.
Publicado: (2016)

ALEXITHYMIA IN IRRITABLE BOWEL SYNDROME
por: Arun, Priti
Publicado: (1998)

Probiotics and irritable bowel syndrome
por: Korpela, Riitta, et al.
Publicado: (2012)

The epidemiology of irritable bowel syndrome
por: Canavan, Caroline, et al.
Publicado: (2014)

Diet in irritable bowel syndrome
por: El-Salhy, Magdy, et al.
Publicado: (2015)

Genetics of irritable bowel syndrome
por: Henström, Maria, et al.
Publicado: (2016)

Epidemiology of irritable bowel syndrome
por: Endo, Yuka, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0o339gqe0gvbn5m81k29bgh9jb